Hereditary non-medullary thyroid cancer

World Journal of Surgery

Volumn 32, Issue 5, 2008, Pages 678-682

  Kebebew, Electron ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE;

ANAMNESIS; CANCER MORTALITY; CANCER PATIENT; CANCER RISK; CANCER SCREENING; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CLINICAL FEATURE; DISEASE FREE SURVIVAL; FAMILIAL CANCER; GENETIC SUSCEPTIBILITY; HEREDITARY NON MEDULLARY THYROID CANCER; HUMAN; LYMPH NODE METASTASIS; POSTOPERATIVE CARE; REVIEW; SURVIVAL RATE; THYROID CANCER; THYROIDECTOMY;

ADENOCARCINOMA, FOLLICULAR; ADENOMA; HUMANS; NEOPLASTIC SYNDROMES, HEREDITARY; PROGNOSIS; THYROID NEOPLASMS;

EID: 42449125254     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-007-9312-z     Document Type: Review

References (28)

1. Pal T, Vogl FD, Chappuis PO, et al. (2001) Increased risk for nonmedullary thyroid cancer in the first degree relatives of prevalent cases of nonmedullary thyroid cancer: a hospital-based study. J Clin Endocrinol Metab 86:5307-5312
2. Hemminki K, Dong C (2000) Familial relationships in thyroid cancer by histopathological type. Int J Cancer 85:201-205
3. Ron E, Kleinerman RA, LiVolsi VA, et al. (1991) Familial nonmedullary thyroid cancer. Oncology 48:309-311
4. Burgess JR, Duffield A, Wilkinson SJ, et al. (1997) Two families with an autosomal dominant inheritance pattern for papillary carcinoma of the thyroid. J Clin Endocrinol Metab 82:345-348
5. Goldgar DE, Easton DF, Cannon-Albright LA, et al. (1994) Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 86:1600-1608
6. Gorson D (1992) Familial papillary carcinoma of the thyroid. Thyroid 2:131-132
7. Ron E, Kleinerman RA, Boice JD Jr., et al. (1987) A population-based case-control study of thyroid cancer. J Natl Cancer Inst 79:1-12
8. Hemminki K, Eng C, Chen B (2005) Familial risks for nonmedullary thyroid cancer. J Clin Endocrinol Metab 90:5747-5753
9. Bevan S, Pal T, Greenberg CR, et al. (2001) A comprehensive analysis of MNG1, TCO1, fPTC, PTEN, TSHR, and TRKA in familial nonmedullary thyroid cancer: confirmation of linkage to TCO1. J Clin Endocrinol Metab 86:3701-3704
10. Bignell GR, Canzian F, Shayeghi M, et al. (1997) Familial nontoxic multinodular thyroid goiter locus maps to chromosome 14q but does not account for familial nonmedullary thyroid cancer. Am J Hum Genet 61:1123-1130
11. Canzian F, Amati P, Harach HR, et al. (1998) A gene predisposing to familial thyroid tumors with cell oxyphilia maps to chromosome 19p13.2. Am J Hum Genet 63:1743-1748
12. Leprat F, Bonichon F, Guyot M, et al. (1999) Familial non-medullary thyroid carcinoma: pathology review in 27 affected cases from 13 French families. Clin Endocrinol (Oxf) 50:589-594
13. Lesueur F, Stark M, Tocco T, et al. (1999) Genetic heterogeneity in familial nonmedullary thyroid carcinoma: exclusion of linkage to RET, MNG1, and TCO in 56 families. NMTC Consortium. J Clin Endocrinol Metab 84:2157-2162
14. McKay JD, Lesueur F, Jonard L, et al. (2001) Localization of a susceptibility gene for familial nonmedullary thyroid carcinoma to chromosome 2q21. Am J Hum Genet 69:440-446
15. Malchoff CD, Sarfarazi M, Tendler B, et al. (2000) Papillary thyroid carcinoma associated with papillary renal neoplasia: genetic linkage analysis of a distinct heritable tumor syndrome. J Clin Endocrinol Metab 85:1758-1764
16. Stankov K, Pastore A, Toschi L, et al. (2004) Allelic loss on chromosomes 2q21 and 19p 13.2 in oxyphilic thyroid tumors. Int J Cancer 111:463-467
17. Carkes ND (1998) On the prevalence of familial nonmedullary thyroid cancer. Thyroid 8:857-858
18. Charkes ND (2006) On the prevalence of familial nonmedullary thyroid cancer in multiply affected kindreds. Thyroid 16:181-186
19. Bonora E, Evangelisti C, Bonichon F, et al. (2006) Novel germline variants identified in the inner mitochondrial membrane transporter TIMM44 and their role in predisposition to oncocytic thyroid carcinomas. Br J Cancer 95:1529-1536
20. Tsilchorozidou T, Vafiadou E, Yovos JG, et al. (2005) A Greek family with a follicular variant of familial papillary thyroid carcinoma: TCO, MNG1, fPTC/PRN, and NMTC1 excluded as susceptibility loci. Thyroid 15:1349-1354
21. Grossman RF, Tu SH, Duh QY, et al. (1995) Familial nonmedullary thyroid cancer. An emerging entity that warrants aggressive treatment. Arch Surg 130:892-897; discussion 898-899
22. Alsanea O, Wada N, Ain K, et al. (2000) Is familial non-medullary thyroid carcinoma more aggressive than sporadic thyroid cancer? A multicenter series. Surgery 128:1043-1050; discussion 1050-1041
23. Loh KC (1997) Familial nonmedullary thyroid carcinoma: a meta-review of case series. Thyroid 7:107-113
24. Lupoli G, Vitale G, Caraglia M, et al. (1999) Familial papillary thyroid microcarcinoma: a new clinical entity. Lancet 353:637-639
25. Triponez F, Wong M, Sturgeon C, et al. (2006) Does familial non-medullary thyroid cancer adversely affect survival? World J Surg 30:787-793
26. Uchino S, Noguchi S, Kawamoto H, et al. (2002) Familial nonmedullary thyroid carcinoma characterized by multifocality and a high recurrence rate in a large study population. World J Surg 26:897-902
27. Maxwell EL, Hall FT, Freeman JL (2004) Familial non-medullary thyroid cancer: a matched-case control study. Laryngoscope 114:2182-2186
28. Uchino S, Noguchi S, Yamashita H, et al. (2004) Detection of asymptomatic differentiated thyroid carcinoma by neck ultrasonographic screening for familial nonmedullary thyroid carcinoma. World J Surg 28:1099-1102